Skip to main content
Ethan Lerner, MD, Dermatology, Charlestown, MA

Ethan A Lerner MD PhD


Associate Professor of Dermatology, Massachusetts General Hospital

Join to View Full Profile
  • Mass. General Hosp -EastBuilding 149, 13th St.Charlestown, MA 02129

  • Phone+1 617-726-4439

Dr. Lerner is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Mass General Brigham/Massachusetts General Hospital/Beth Israel Deaconess Medical Center/Brigham and Women's Hosp
    Mass General Brigham/Massachusetts General Hospital/Beth Israel Deaconess Medical Center/Brigham and Women's HospResidency, Dermatology, 1984 - 1987
  • University of Washington
    University of WashingtonResidency, Internal Medicine, 1982 - 1984
  • Yale School of Medicine
    Yale School of MedicineClass of 1982

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1984 - 2025
  • ME State Medical License
    ME State Medical License Active through 1990
  • Dermatology
    American Board of Dermatology Dermatology

Awards, Honors, & Recognition

  • Fellow (FAAD) American Academy of Dermatology

Publications & Presentations

PubMed

Lectures

  • Chronic Pruritus: Bedside to Bench Perspectives 
    American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/1/2019
  • 7th World Congress on ITCH 
    International Forum for the Study of Itch, Boston, Massachusetts - 9/21/2013

Press Mentions

  • Prominent Investigators Receive NEA Grants Targeting Eczema Research: Over 30m Underserved Patients in USA Alone
    Prominent Investigators Receive NEA Grants Targeting Eczema Research: Over 30m Underserved Patients in USA AloneDecember 23rd, 2020
  • Escient Pharmaceuticals Launches with $40 Million Series A Financing to Advance First-in-Class G Protein-Coupled Receptor (GPCR)-Targeted Drugs to Address Serious, Unserved Medical Needs
    Escient Pharmaceuticals Launches with $40 Million Series A Financing to Advance First-in-Class G Protein-Coupled Receptor (GPCR)-Targeted Drugs to Address Serious, Unserved Medical NeedsMay 9th, 2018
  • Pick the Right Products to Stop Itchy Skin
    Pick the Right Products to Stop Itchy SkinAugust 5th, 2017
  • Join now to see all

Grant Support

  • Neuronal MRGPR signaling in itch and allergic skin inflammationMASSACHUSETTS GENERAL HOSPITAL2023–2028
  • Itch, Proteases And Protease-Activated ReceptorsNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2010–2011
  • G-Protein Coupled Receptors For Bioagent DetectionNational Institute Of Allergy And Infectious Diseases2004–2006
  • Cutaneous Biology Of Nitric OxideNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1998–2002
  • Maxadilan, A Cutaneous Vasodilator From Sand FliesNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1994–2002

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: